Factors influencing drug switching and changes in low-density lipoprotein-cholesterol levels with atorvastatin: a real-world observational study

被引：0
|
作者：
Yu-Cheol Lim
Eui-Kyung Lee
Mi-Hai Park
机构：
[1] Sungkyunkwan University,School of Pharmacy
来源：
Lipids in Health and Disease | / 22卷
关键词：
Drug switching; Generic drug; Atorvastatin; Low-density lipoprotein-cholesterol; Real-world data;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Effects of Paroxetine and Sertraline on Low-Density Lipoprotein Cholesterol An Observational Cohort Study
    Wei, Feifei
    Crain, A. Lauren
    Whitebird, Robin R.
    Godlevsky, Olga V.
    O'Connor, Patrick J.
    CNS DRUGS, 2009, 23 (10) : 857 - 865
  • [32] Association of Longitudinal Changes in Serum Mac-2 Binding Protein and Low-Density Lipoprotein Cholesterol Levels: A Prospective Observational Study
    Sugiura, Tomonori
    Dohi, Yasuaki
    Takase, Hiroyuki
    Mizoguchi, Tatsuya
    Tanaka, Yasuhito
    Ohte, Nobuyuki
    CIRCULATION, 2018, 138
  • [33] Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels
    Ai, Masumi
    Otokozawa, Seiko
    Asztalos, Bela F.
    Nakajima, Katsuyuki
    Stein, Evan
    Jones, Peter H.
    Schaefer, Ernst J. f
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (03): : 315 - 318
  • [34] Low-density lipoprotein cholesterol reduction and target achievement after switching from statin monotherapy to statin/ezetimibe combination therapy: Real-world evidence
    Lee, Jeongmin
    Lee, Sue Hyun
    Kim, Hyunah
    Lee, Seung-Hwan
    Cho, Jae Hyoung
    Lee, Hyunyong
    Yim, Hyeon Woo
    Yoon, Kun-Ho
    Kim, Hun-Sung
    Kim, Ju Han
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (01) : 134 - 142
  • [35] High low-density lipoprotein cholesterol levels in people with HIV by individual cardiovascular risk: A retrospective observational study
    Carrozzo, Giorgia
    Caloni, Beatrice
    Giacomelli, Andrea
    Oreni, Letizia
    Caronni, Stefania
    Lazzarin, Samuel
    Poloni, Andrea
    Pagano, Simone
    Colombo, Martina Laura
    Beltrami, Martina
    Casalini, Giacomo
    Maggioni, Aldo Pietro
    Gervasoni, Cristina
    Ridolfo, Anna Lisa
    Antinori, Spinello
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2025, 420
  • [36] Additional role of low-density lipoprotein cholesterol on the risk of osteoporosis in men with or without coronary heart disease: a real-world longitudinal study
    Jing ZENG
    ZiMo PAN
    Ting LI
    ZeYu CHEN
    XiaoYan CAI
    MeiLiang GONG
    XinLi DENG
    ShengShu WANG
    Nan LI
    Miao LIU
    ChunLin LI
    Journal of Geriatric Cardiology, 2025, 22 (02) : 219 - 228
  • [37] Dyslipidemia treatment patterns and low-density lipoprotein cholesterol monitoring and management of patients with atherosclerosis in real-world clinical practice
    Fox, Kathleen M.
    Gandhi, Sanjay K.
    Blasetto, James W.
    Ohsfeldt, Robert L.
    Grandy, Susan
    Davidson, Michael H.
    CIRCULATION, 2007, 115 (21) : E572 - E572
  • [38] Low-density lipoprotein-cholesterol and risk of chronic obstructive pulmonary disease: A prospective study of 107.301 participants
    Freyberg, J.
    Afzal, S.
    Landt, E. M.
    Nordestgaard, B. G.
    Dahl, M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [39] Rare and common variants of APOB and PCSK9 in Korean patients with extremely low low-density lipoprotein-cholesterol levels
    Lee, Chan Joo
    Lee, Yunbeom
    Park, Sungha
    Kang, Seok-Min
    Jang, Yangsoo
    Lee, Ji Hyun
    Lee, Sang-Hak
    PLOS ONE, 2017, 12 (10):
  • [40] Determinants of Plaque Progression Despite Very Low Low-Density Lipoprotein-Cholesterol Levels With the PCSK9 Inhibitor, Evolocumab
    Honda, Satoshi
    Puri, Rishi
    Anderson, Todd
    Kastelein, John J. P.
    Brennan, Danielle M.
    Kassahun, Helina
    Somaratne, Ransi
    Wasserman, Scott M.
    Nissen, Steve E.
    Nicholls, Stephen J.
    JACC-CARDIOVASCULAR IMAGING, 2022, 15 (04) : 709 - 711
12345